PNTG

The Pennant Group Inc.

Price

$41.25

return (12m)

76.06%

p/e

48.21

p/bv

3.75

DIVIDEND YIELD

0.00%

PNTG price

Pennant Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PNTG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

23.36%

3 months

42.73%

1 year

76.06%

2 years

51.99%

5 years

11.46%

10 years

0.00%

Fundamentals PNTG

Valuation

P/E

48.21

Sector -2.36

Industry 0.98

P/BV

3.75

Sector 2.16

Industry 2.53

P/Revenue (PSR)

1.43

Sector 2.00

Industry 0.76

P/EBITDA

22.10

Sector -0.13

Industry 1.08

P/EBIT

25.70

Sector -2.10

Industry 3.17

P/Total Assets

1.53

Sector 1.17

Industry 0.93

EPS

0.87

Sector -0.93

Industry -0.57

BVPS

11.13

Sector 3.88

Industry 5.17

Efficiency

Gross Margin

13.75%

Sector 44.07%

Industry 30.88%

Operating Margin

5.43%

Sector -25.88%

Industry -7.64%

Net Profit Margins

2.96%

Sector -30.34%

Industry -16.97%

Profitability

ROE

7.79%

Sector -34.57%

Industry -29.67%

ROA

3.17%

Sector -28.64%

Industry -15.42%

ROIC

5.95%

Sector -441.27%

Industry -111.79%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Debt

Equity/Assets

0.41

Sector 0.43

Industry 0.26

Liabilities/Assets

0.59

Sector 0.46

Industry 0.48

Growth

5Y Revenue CAGR

18.40%

Sector -

Industry -

5Y Earnings CAGR

62.21%

Sector -

Industry -

FAIR VALUE OF Pennant Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$41.25

Fair Value

$14.76

Upside Return potential.

-64.22%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PNTG

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
PNTG	48.21	3.75	7.79%	0.00%	$1.46 B	2.96%
CI	11.58	1.78	15.39%	2.16%	$75.20 B	2.34%
UHS	6.06	1.21	20.00%	0.53%	$9.22 B	8.56%
DGX	22.66	3.00	13.22%	1.55%	$23.20 B	9.08%
STRRP	8.16	2.56	31.31%	9.43%	$163.57 M	25.96%
ENSG	27.54	4.22	15.33%	0.15%	$10.01 B	6.89%
CRVL	28.24	7.90	27.99%	0.00%	$3.12 B	11.51%
JYNT	38.39	8.03	20.92%	0.00%	$124.39 M	5.72%
OPCH	16.48	2.51	15.26%	0.00%	$3.40 B	3.64%
MGLN	8.00	1.53	19.13%	0.00%	$2.42 B	6.38%
PGNY	37.63	5.80	15.40%	0.00%	$2.55 B	5.23%
VAR	58.58	7.26	12.40%	0.00%	$16.26 B	5.85%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PNTG Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Pennant Group

The Pennant Group Inc.

Average Investor10 user rating

4.0 (0 people)

United States

7 years

Founded: 2019

2019

Time since IPO - 7 years

-

Employees

The Pennant Group Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.46 billion, with shareholders equity totaling $389.44 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, The Pennant Group Inc. reported $1.02 billion in revenue, generating net income of $30.32 million.

Key financial metrics include a P/E ratio of 48.21, a price-to-book (P/B) ratio of 3.75, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PNTG.

Market cap

$1.46 billion

Net worth

$389.44 million

$389,440,000.00

Assets

$956.48 million

$956,480,000.00

Total Shares Outstanding

35.00 million

35,000,000

Average Daily Trading Volume

$315.30 Thousand

$315,296.00

Sector

Health

Industry

Health Establishments

PNTG

PNTG revenue and profits

Financial Results PNTG

DRAG THE FRAME TO SEE MORE DATA

PNTG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$109.45 85,17% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$287.16 --0,45% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$67.22 145,04% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$407.13 85,54% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.80 --5,01% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,163.75 51,17% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$371.79 2,66% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$154.86 38,31% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56